Largest Hospital Group to CMS: 340B Drug Survey Is Burdensome, Ill-Timed, Illegal


A note from 340B Report CEO and Publisher Ted Slafsky: Today’s issue includes the third in our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below

Read More »

All Indications Are CMS Plans to Launch its 340B Drug Acquisition Survey on Monday

Editor’s note, March 20, 2020: When we published Tweets of Note yesterday, we were unaware of health care economist’s Rena Conti’s March 14 reply to a critic’s tweet the same day. We have added it to this web version of

Read More »

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Do 340B drug discounts induce hospitals to furnish more-expensive drugs to treat cancer than they otherwise would, raising patients’ coinsurance obligations and the cost of

Read More »

Welcome To 340B Report From Publisher & CEO Ted Slafsky

Dear Friends and Colleagues,

In addition to my role as Founder of Wexford Solutions, I am very pleased to announce the launch of a new venture—340B Report. 340B Report is the only independent subscription news service that provides regular

Read More »

Think Tank to States: Use 340B to Reduce Drug Prices

Think Tank to States: Use 340B to Reduce Drug Prices

States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the

Read More »

CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs

CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs

The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’

Read More »

Hospital Group: GAO’s 340B Duplicate Discount Recommendations “Contrary to Federal Law”

Hospital Group: GAO’s 340B Duplicate Discount Recommendations “Contrary to Federal Law”

Hospital group 340B Health yesterday swung back hard against a congressional watchdog agency’s recommendations for stricter federal policing of 340B duplicate discounts, calling them “misguided, unworkable, and contrary

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live